Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 179

1.

Subtype C gp140 vaccine boosts immune responses primed by SAAVI DNA-C2 and MVA-C HIV vaccine after more than a two year gap (HVTN 073E/SAAVI 102).

Gray GE, Mayer KH, Elizaga ML, Bekker LG, Allen M, Morris L, Montefiori D, De Rosa SC, Sato A, Gu N, Tomaras GD, Tucker T, Barnett SW, Mkhize NN, Shen X, Downing K, Williamson C, Pensiero M, Corey L, Williamson AL; NIAID-funded HIV Vaccine Trials Network.

Clin Vaccine Immunol. 2016 Apr 20. pii: CVI.00717-15. [Epub ahead of print]

2.

Female genital tract inflammation, HIV co-infection and persistent mucosal Human Papillomavirus (HPV) infections.

Kriek JM, Jaumdally SZ, Masson L, Little F, Mbulawa Z, Gumbi PP, Barnabas SL, Moodley J, Denny L, Coetzee D, Williamson AL, Passmore JA.

Virology. 2016 Jun;493:247-54. doi: 10.1016/j.virol.2016.03.022. Epub 2016 Apr 11.

PMID:
27065342
3.

Cumulative Impact of HIV and Multiple Concurrent Human Papillomavirus Infections on the Risk of Cervical Dysplasia.

Adler DH, Wallace M, Bennie T, Abar B, Meiring TL, Williamson AL, Bekker LG.

Adv Virol. 2016;2016:7310894. doi: 10.1155/2016/7310894. Epub 2016 Feb 22.

4.

High Burden of Human Papillomavirus (HPV) Infection among Young Women in KwaZulu-Natal, South Africa.

Ebrahim S, Mndende XK, Kharsany AB, Mbulawa ZZ, Naranbhai V, Frohlich J, Werner L, Samsunder N, Karim QA, Williamson AL.

PLoS One. 2016 Jan 19;11(1):e0146603. doi: 10.1371/journal.pone.0146603. eCollection 2016.

5.

Prospective One Year Follow Up of HIV Infected Women Screened for Cervical Cancer Using Visual Inspection with Acetic Acid, Cytology and Human Papillomavirus Testing in Johannesburg South Africa.

Firnhaber C, Goeieman B, Faesen M, Levin S, Williams S, Rameotshela S, Swarts A, Michelow P, Omar T, Williamson AL, Allan B, Schnippel K, Smith JS.

PLoS One. 2016 Jan 5;11(1):e0144905. doi: 10.1371/journal.pone.0144905. eCollection 2016.

6.

Justification for the inclusion of Gag in HIV vaccine candidates.

Williamson AL, Rybicki EP.

Expert Rev Vaccines. 2016 May;15(5):585-98. doi: 10.1586/14760584.2016.1129904. Epub 2015 Dec 28.

PMID:
26645951
7.

Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status.

Mbulawa ZZ, Coetzee D, Williamson AL.

BMC Infect Dis. 2015 Oct 26;15:459. doi: 10.1186/s12879-015-1181-8.

9.
10.

The Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in Africa.

Williamson AL.

J Clin Med. 2015 Apr 2;4(4):579-92. doi: 10.3390/jcm4040579. Review.

11.

Six host-range restricted poxviruses from three genera induce distinct gene expression profiles in an in vivo mouse model.

Offerman K, Deffur A, Carulei O, Wilkinson R, Douglass N, Williamson AL.

BMC Genomics. 2015 Jul 8;16:510. doi: 10.1186/s12864-015-1659-1.

12.

Transient global T cell activation after vaccination of rhesus macaques with a DNA-poxvirus vaccine regimen for HIV.

Soares A, Müller TL, Chege GK, Williamson AL, Burgers WA.

Vaccine. 2015 Jul 9;33(30):3435-9. doi: 10.1016/j.vaccine.2015.05.072. Epub 2015 Jun 10.

PMID:
26055294
13.

High risk human papillomavirus persistence among HIV-infected young women in South Africa.

Adler D, Wallace M, Bennie T, Abar B, Sadeghi R, Meiring T, Williamson AL, Bekker LG.

Int J Infect Dis. 2015 Apr;33:219-21. doi: 10.1016/j.ijid.2015.02.009. Epub 2015 Feb 17.

14.

Cervical dysplasia and high-risk human papillomavirus infections among HIV-infected and HIV-uninfected adolescent females in South Africa.

Adler DH, Wallace M, Bennie T, Mrubata M, Abar B, Meiring TL, Williamson AL, Bekker LG.

Infect Dis Obstet Gynecol. 2014;2014:498048. doi: 10.1155/2014/498048. Epub 2014 Oct 20.

15.

The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG).

Chen RT, Carbery B, Mac L, Berns KI, Chapman L, Condit RC, Excler JL, Gurwith M, Hendry M, Khan AS, Khuri-Bulos N, Klug B, Robertson JS, Seligman SJ, Sheets R, Williamson AL; V3SWG.

Vaccine. 2015 Jan 1;33(1):73-5. doi: 10.1016/j.vaccine.2014.09.035. Epub 2014 Oct 8.

16.

The use of directed evolution to create a stable and immunogenic recombinant BCG expressing a modified HIV-1 Gag antigen.

Chapman R, Bourn WR, Shephard E, Stutz H, Douglass N, Mgwebi T, Meyers A, Chin'ombe N, Williamson AL.

PLoS One. 2014 Jul 25;9(7):e103314. doi: 10.1371/journal.pone.0103314. eCollection 2014.

17.

The complete genome sequences of poxviruses isolated from a penguin and a pigeon in South Africa and comparison to other sequenced avipoxviruses.

Offerman K, Carulei O, van der Walt AP, Douglass N, Williamson AL.

BMC Genomics. 2014 Jun 12;15:463. doi: 10.1186/1471-2164-15-463.

18.

The novel capripoxvirus vector lumpy skin disease virus efficiently boosts modified vaccinia Ankara human immunodeficiency virus responses in rhesus macaques.

Burgers WA, Ginbot Z, Shen YJ, Chege GK, Soares AP, Müller TL, Bunjun R, Kiravu A, Munyanduki H, Douglass N, Williamson AL.

J Gen Virol. 2014 Oct;95(Pt 10):2267-72. doi: 10.1099/vir.0.067835-0. Epub 2014 May 27.

PMID:
24866849
19.

Radionuclide release from simulated waste material after biogeochemical leaching of uraniferous mineral samples.

Williamson AL, Caron F, Spiers G.

J Environ Radioact. 2014 Dec;138:308-14. doi: 10.1016/j.jenvrad.2014.03.004. Epub 2014 Apr 13.

PMID:
24726552
20.

Comprehensive profiling of the vaginal microbiome in HIV positive women using massive parallel semiconductor sequencing.

Ameur A, Meiring TL, Bunikis I, Häggqvist S, Lindau C, Lindberg JH, Gustavsson I, Mbulawa ZZ, Williamson AL, Gyllensten U.

Sci Rep. 2014 Mar 18;4:4398. doi: 10.1038/srep04398.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk